Claes C. Strom - Search Results

Year	Number of Results
2002	1
2003	1
2004	1
2005	2
2006	1
2007	1
2017	1
2019	1
2020	2
2022	1
2024	1

1

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.

Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, Ahmed FZ, Al-Mohammad A, Cowburn PJ, Foley PWX, Graham FJ, Japp AG, Lane RE, Lang NN, Ludman AJ, Macdougall IC, Pellicori P, Ray R, Robertson M, Seed A, Ford I; IRONMAN Study Group. Kalra PR, et al. Lancet. 2022 Dec 17;400(10369):2199-2209. doi: 10.1016/S0140-6736(22)02083-9. Epub 2022 Nov 5. Lancet. 2022. PMID: 36347265 Free article. Clinical Trial.

2

Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.

Cleland JGF, Kalra PA, Pellicori P, Graham FJ, Foley PWX, Squire IB, Cowburn PJ, Seed A, Clark AL, Szwejkowski B, Banerjee P, Cooke J, Francis M, Clifford P, Wong A, Petrie C, McMurray JJV, Thomson EA, Wetherall K, Robertson M, Ford I, Kalra PR; IRONMAN Study Group. Cleland JGF, et al. Eur Heart J. 2024 Apr 21;45(16):1410-1426. doi: 10.1093/eurheartj/ehae086. Eur Heart J. 2024. PMID: 38446126 Free PMC article. Clinical Trial.

3

Comment on 'Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures'.

Schaffalitzky de Muckadell P, Strom CC. Schaffalitzky de Muckadell P, et al. Drug Saf. 2020 May;43(5):503-505. doi: 10.1007/s40264-020-00929-0. Drug Saf. 2020. PMID: 32253716 Free PMC article. No abstract available.

4

Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro.

Busk PK, Wulf-Andersen L, Strøm CC, Enevoldsen M, Thirstrup K, Haunsø S, Sheikh SP. Busk PK, et al. Among authors: strom cc. Exp Cell Res. 2003 May 15;286(1):102-14. doi: 10.1016/s0014-4827(03)00091-0. Exp Cell Res. 2003. PMID: 12729799

5

Comment on 'Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017'.

Schaffalitzky de Muckadell P, Strom CC. Schaffalitzky de Muckadell P, et al. Drug Saf. 2019 May;42(5):689-691. doi: 10.1007/s40264-019-00814-5. Drug Saf. 2019. PMID: 30937852 Free PMC article. No abstract available.

6

Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017.

Durup D, Schaffalitzky de Muckadell P, Strom CC. Durup D, et al. Expert Rev Hematol. 2020 May;13(5):557-564. doi: 10.1080/17474086.2020.1738215. Epub 2020 Mar 17. Expert Rev Hematol. 2020. PMID: 32129113

7

Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy.

Christoffersen TE, Aplin M, Strom CC, Sheikh SP, Skott O, Busk PK, Haunso S, Nielsen LB. Christoffersen TE, et al. Among authors: strom cc. Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1635-41. doi: 10.1152/ajpheart.00612.2005. Epub 2005 Nov 4. Am J Physiol Heart Circ Physiol. 2006. PMID: 16272201 Free article.

8

Comment on Neiser et al. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA). Int. J. Mol. Sci. 2016, 17, 1185.

Strom CC, Andreasen HB. Strom CC, et al. Int J Mol Sci. 2017 Jan 10;18(1):121. doi: 10.3390/ijms18010121. Int J Mol Sci. 2017. PMID: 28075402 Free PMC article.

9

Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro.

Busk PK, Bartkova J, Strøm CC, Wulf-Andersen L, Hinrichsen R, Christoffersen TE, Latella L, Bartek J, Haunsø S, Sheikh SP. Busk PK, et al. Among authors: strom cc. Cardiovasc Res. 2002 Oct;56(1):64-75. doi: 10.1016/s0008-6363(02)00510-2. Cardiovasc Res. 2002. PMID: 12237167

10

S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes.

Schneider M, Kostin S, Strøm CC, Aplin M, Lyngbaek S, Theilade J, Grigorian M, Andersen CB, Lukanidin E, Lerche Hansen J, Sheikh SP. Schneider M, et al. Among authors: strom cc. Cardiovasc Res. 2007 Jul 1;75(1):40-50. doi: 10.1016/j.cardiores.2007.03.027. Epub 2007 Apr 6. Cardiovasc Res. 2007. PMID: 17466960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year